These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 4047079)

  • 41. Mutagenesis at the ouabain-resistance locus of 3.7.2C L5178Y cells by chromosomal mutagens.
    Amacher DE; Dunn EM
    Environ Mutagen; 1985; 7(4):523-33. PubMed ID: 2996875
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Point mutations at the thymidine kinase locus in L5178Y mouse lymphoma cells. II. Test validation and interpretation.
    Amacher DE; Paillet SC; Turner GN; Ray VA; Salsburg DS
    Mutat Res; 1980 Aug; 72(3):447-74. PubMed ID: 7453708
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Molecular analysis of mutations at the tk locus of L5178Y mouse-lymphoma cells induced by ethyl methanesulphonate and mitomycin C.
    Davies MJ; Phillips BJ; Rumsby PC
    Mutat Res; 1993 Dec; 290(2):145-53. PubMed ID: 7694105
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mutagenicity and clastogenicity of 3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone (MX) in L5178Y/TK+/(-)-3.7.2C mouse lymphoma cells.
    Harrington-Brock K; Doerr CL; Moore MM
    Mutat Res; 1995 Nov; 348(3):105-10. PubMed ID: 8524361
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Preliminary molecular analysis of the TK locus in L5178Y large- and small-colony mouse lymphoma cell mutants.
    Cobb RR; Martin J; Korytynski E; Monteith L; Hughes TJ
    Mutat Res; 1989 Aug; 226(4):253-8. PubMed ID: 2761566
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Analysis of large and small colony L5178Y tk-/- mouse lymphoma mutants by loss of heterozygosity (LOH) and by whole chromosome 11 painting: detection of recombination.
    Liechty MC; Scalzi JM; Sims KR; Crosby H; Spencer DL; Davis LM; Caspary WJ; Hozier JC
    Mutagenesis; 1998 Sep; 13(5):461-74. PubMed ID: 9800191
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The use of L5178Y mouse lymphoma cells to assess the mutagenic, clastogenic and aneugenic properties of chemicals.
    Combes RD; Stopper H; Caspary WJ
    Mutagenesis; 1995 Sep; 10(5):403-8. PubMed ID: 8544753
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Methapyrilene is a genotoxic carcinogen: studies on methapyrilene and pyrilamine in the L5178Y/TK +/- mouse lymphoma assay.
    Turner NT; Woolley JL; Hozier JC; Sawyer JR; Clive D
    Mutat Res; 1987 Nov; 189(3):285-97. PubMed ID: 3670332
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The evaluation of the use of 10% rather than 20% horse serum in the cloning and selection of TK-/- mutants of L5178Y/TK+/- mouse lymphoma cells.
    Moore MM; Loud K; Templeton RK
    Mutat Res; 1984 Aug; 140(4):215-8. PubMed ID: 6472332
    [No Abstract]   [Full Text] [Related]  

  • 50. Bromate induces loss of heterozygosity in the thymidine kinase gene of L5178Y/Tk(+/-)-3.7.2C mouse lymphoma cells.
    Harrington-Brock K; Collard DD; Chen T
    Mutat Res; 2003 May; 537(1):21-8. PubMed ID: 12742504
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mutagenicity of actinomycin D in mammalian cells due to clastogenic effects.
    DeMarini DM; Brock KH; Doerr CL; Moore MM
    Mutat Res; 1987 Oct; 192(2):151-5. PubMed ID: 3657844
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mutant frequency and mutational spectra in the Tk and Hprt genes of N-ethyl-N-nitrosourea-treated mouse lymphoma cellsdagger.
    Chen T; Harrington-Brock K; Moore MM
    Environ Mol Mutagen; 2002; 39(4):296-305. PubMed ID: 12112381
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mutagenicity of m-AMSA and o-AMSA in mammalian cells due to clastogenic mechanism: possible role of topoisomerase.
    DeMarini DM; Doerr CL; Meyer MK; Brock KH; Hozier J; Moore MM
    Mutagenesis; 1987 Sep; 2(5):349-55. PubMed ID: 2830452
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Microarray analysis distinguishes differential gene expression patterns from large and small colony Thymidine kinase mutants of L5178Y mouse lymphoma cells.
    Han T; Wang J; Tong W; Moore MM; Fuscoe JC; Chen T
    BMC Bioinformatics; 2006 Sep; 7 Suppl 2(Suppl 2):S9. PubMed ID: 17118152
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ascorbate is detectably mutagenic in the L5178Y TK+/- cell mutation assay.
    Amacher DE; Paillet SC
    Cancer Lett; 1981 Nov; 14(2):151-8. PubMed ID: 7317878
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Localization of the mouse thymidine kinase gene to the distal portion of chromosome 11.
    Hozier J; Scalzi J; Sawyer J; Carley N; Applegate M; Clive D; Moore MM
    Genomics; 1991 Jul; 10(3):827-30. PubMed ID: 1889822
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Multi-endpoint genotoxic assay using L5178Y (Tk(+/-) -3.7.2c) cells.
    Ogawa I; Furukawa S; Abe M; Tanaka Y; Hayashi S; Usuda K
    J Toxicol Sci; 2009 Oct; 34(5):547-53. PubMed ID: 19797863
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Do trifluorothymidine-resistant mutants of L5178Y mouse lymphoma cells re-express thymidine kinase activity following 5-azacytidine treatment?
    Moore MM; Applegate ML; Hozier JC
    Mutat Res; 1988 Feb; 207(2):77-82. PubMed ID: 2448615
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Use of microsatellite DNA polymorphisms on mouse chromosome 11 for in vitro analysis of thymidine kinase gene mutations.
    Liechty MC; Hassanpour Z; Hozier JC; Clive D
    Mutagenesis; 1994 Sep; 9(5):423-7. PubMed ID: 7837976
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Validation and characterization of the L5178Y/TK+/- mouse lymphoma mutagen assay system.
    Clive D; Johnson KO; Spector JF; Batson AG; Brown MM
    Mutat Res; 1979 Jan; 59(1):61-108. PubMed ID: 372791
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.